These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1379859)

  • 1. Natural killer cell surface markers on cells containing parallel tubular structures.
    Hoogeveen YL; Blom NR; Halie MR; Smit JW
    Nat Immun; 1992; 11(2):69-77. PubMed ID: 1379859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3 negative "small agranular lymphocytes" are natural killer cells.
    Inverardi L; Witson JC; Fuad SA; Winkler-Pickett RT; Ortaldo JR; Bach FH
    J Immunol; 1991 Jun; 146(11):4048-52. PubMed ID: 1827820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
    Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
    Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold method.
    Polli N; Matutes E; Robinson D; Catovsky D
    Clin Exp Immunol; 1987 May; 68(2):331-9. PubMed ID: 3498572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.
    Pang G; Buret A; Batey RT; Chen QY; Couch L; Cripps A; Clancy R
    Immunology; 1993 Jul; 79(3):498-505. PubMed ID: 7691728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative disorder of granular lymphocytes. A heterogeneous disease.
    McDaniel HL; MacPherson BR; Tindle BH; Lunde JH
    Arch Pathol Lab Med; 1992 Mar; 116(3):242-8. PubMed ID: 1371379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2.
    Tompkins MB; Pang VF; Michaely PA; Feinmehl RI; Basgall EJ; Baszler TV; Zachary JF; Tompkins WA
    J Immunol; 1989 Jul; 143(2):749-54. PubMed ID: 2544649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoultrastructural studies of human NK cells: I. Ultracytochemistry and comparison with T cell subsets.
    Kang YH; Carl M; Grimley PM; Serrate S; Yaffe L
    Anat Rec; 1987 Mar; 217(3):274-89. PubMed ID: 3555161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
    J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of lymphocyte phenotype and T cell receptor genotype in Felty's syndrome.
    Meliconi R; Kingsley GH; Pitzalis C; Sakkas L; Panayi GS
    J Rheumatol; 1992 Jul; 19(7):1058-64. PubMed ID: 1380988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2.
    Ellis TM; Creekmore SP; McMannis JD; Braun DP; Harris JA; Fisher RI
    Cancer Res; 1988 Nov; 48(22):6597-602. PubMed ID: 2902918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer function in flow cytometry: identification of human lymphoid subsets able to bind to the NK sensitive target K562.
    Vitale M; Zamai L; Neri LM; Manzoli L; Facchini A; Papa S
    Cytometry; 1991; 12(8):717-22. PubMed ID: 1838975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
    Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
    J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.